F10 and deep vein thrombosis: Since the 1980s, various anticoagulant, such as low molecular weight heparin and factor Xa inhibitors, were recommended to reduce the incidence of symptomatic DVT to 5%–10% (Januel et al., 2012; Falck-Ytter et al., 2012; Lieberman and Bell, 2021), marking a significant advancement in DVT prevention for TJA.